Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Cyteir Therapeutics Inc
(NQ:
CYT
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Mar 15, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Cyteir Therapeutics Inc
< Previous
1
2
3
Next >
Cyteir Announces Timeline for Voluntarily Delisting from Nasdaq
March 07, 2024
From
Cyteir Therapeutics
Via
Business Wire
Ongoing Results From a Dose Expansion Cohort of CYT-0851 in Combination With Capecitabine in Advanced Platinum-Resistant Ovarian Cancer Show Promising Clinical Activity and Generally Well Tolerated Safety Profile
October 12, 2023
From
Cyteir Therapeutics
Via
Business Wire
Nasdaq Jumps 200 Points; Baudax Bio Shares Spike Higher
June 30, 2023
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining around 1.5% on Friday. The Dow traded up 0.93% to 34,439.75 while the NASDAQ rose 1.54% to 13,800.92. The S&P 500,...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
June 30, 2023
Via
Benzinga
Cyteir Therapeutics (NASDAQ: CYT) to Dissolve After Discontinuing Development of CYT-0851
June 30, 2023
Cyteir Announces Halt of CYT-0851 Development and Company Dissolution Biotech firm Cyteir Therapeutics, Inc. (NASDAQ: CYT) announced today its decision
Via
Spotlight Growth
Why Cineverse Shares Are Trading Lower By 18%? Here Are Other Stocks Moving In Friday's Mid-Day Session
June 30, 2023
Gainers Addentax Group Corp. (NASDAQ: ATXG) shares jumped 47.3% to $9.68. Addentax Group is launching automation of artificial intelligence internet operational tools project with top...
Via
Benzinga
Crude Oil Rises Over 1%; Fed's Preferred Inflation Gauge Slows In May
June 30, 2023
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 1% on Friday. The Dow traded up 0.62% to 34,333.42 while the NASDAQ rose 1.37% to 13,777.52. The S&P 500,...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
June 30, 2023
Via
Benzinga
Cyteir Therapeutics Announces Discontinuation of CYT-0851 Development Program and Planned Liquidation and Dissolution
June 30, 2023
From
Cyteir Therapeutics
Via
Business Wire
Preliminary Ongoing Results with CYT-0851 in Combination with Capecitabine or Gemcitabine in Advanced Solid Tumors Show Early Clinical Activity and Generally Well Tolerated Safety Profile
June 03, 2023
From
Cyteir Therapeutics
Via
Business Wire
Cyteir Therapeutics Reports First Quarter 2023 Financial Results and Operational Highlights
May 10, 2023
From
Cyteir Therapeutics, Inc.
Via
Business Wire
Cyteir Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Operational Highlights
March 23, 2023
From
Cyteir Therapeutics
Via
Business Wire
Cyteir Therapeutics Promotes David Gaiero to Chief Financial Officer
February 06, 2023
From
Cyteir Therapeutics
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For February 3, 2023
February 03, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 30, 2023
January 30, 2023
Via
Benzinga
Cyteir Therapeutics Announces Prioritization of CYT-0851 Development and Extended Cash Runway
January 19, 2023
From
Cyteir Therapeutics
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For January 20, 2023
January 20, 2023
Via
Benzinga
Cyteir Therapeutics Reports Third Quarter 2022 Financial Results and Operational Highlights
November 07, 2022
From
Cyteir Therapeutics
Via
Business Wire
Cyteir Therapeutics Presents Poster on the Identification of Mechanism of Action of CYT-0851 at the 34th Annual EORTC-NCI-AACR Symposium
October 12, 2022
From
Cyteir Therapeutics
Via
Business Wire
5 Value Stocks In The Healthcare Sector
September 12, 2022
What are Value Stocks?
Via
Benzinga
Cyteir Therapeutics to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference
August 31, 2022
From
Cyteir Therapeutics
Via
Business Wire
Cyteir Therapeutics Reports Second Quarter 2022 Financial Results and Operational Highlights
August 08, 2022
From
Cyteir Therapeutics
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For September 9, 2022
September 09, 2022
Upgrades
Via
Benzinga
Cyteir Therapeutics to Participate in the 2022 Wedbush PacGrow Healthcare Virtual Conference
August 01, 2022
From
Cyteir Therapeutics
Via
Business Wire
Why This Biotechnology Surged More Than 60%; Here Are 67 Biggest Movers From Yesterday
July 27, 2022
Gainers Ayala Pharmaceuticals, Inc. (NASDAQ: AYLA) shares surged 94.3% to close at $1.69 on Tuesday after the company filed a request for the withdrawal of the Registration Statement on Form S-1.
Via
Benzinga
CYT-0851 Phase 1 Dose Escalation Results Show Early Clinical Activity and Generally Well Tolerated Safety Profile in Advanced Solid Tumors and Hematologic Malignancies
June 05, 2022
From
Cyteir Therapeutics
Via
Business Wire
79 Biggest Movers From Yesterday
June 08, 2022
Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) gained 154.7% to settle at $12.10 on Tuesday on continued strength after the FDA granted clearance for the company's pūrgo technology, classifying it...
Via
Benzinga
Cyteir Therapeutics to Participate in the 2022 Jefferies Healthcare Conference
May 31, 2022
From
Cyteir Therapeutics
Via
Business Wire
83 Biggest Movers From Yesterday
May 06, 2022
Gainers Hudson Technologies, Inc. (NASDAQ: HDSN) shares jumped 26.9% to close at $9.06 on Thursday after the company reported better-than-expected Q1 EPS and sales results.
Via
Benzinga
Cyteir Therapeutics Reports First Quarter 2022 Financial Results and Operational Highlights
May 05, 2022
From
Cyteir Therapeutics
Via
Business Wire
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.